Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice

The serotonin (5-HT) 2A receptor is the primary molecular target of serotonergic hallucinogens, which trigger large-scale perturbations of the cortex. Our understanding of how 5-HT2A activation may cause the effects of hallucinogens has been hampered by the receptor unselectivity of most of the drug...

Full description

Bibliographic Details
Main Authors: Tobias Buchborn, Taylor Lyons, Thomas Knöpfel
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00017/full
_version_ 1818131131631927296
author Tobias Buchborn
Taylor Lyons
Thomas Knöpfel
Thomas Knöpfel
author_facet Tobias Buchborn
Taylor Lyons
Thomas Knöpfel
Thomas Knöpfel
author_sort Tobias Buchborn
collection DOAJ
description The serotonin (5-HT) 2A receptor is the primary molecular target of serotonergic hallucinogens, which trigger large-scale perturbations of the cortex. Our understanding of how 5-HT2A activation may cause the effects of hallucinogens has been hampered by the receptor unselectivity of most of the drugs of this class. Here we used 25CN-NBOH (N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine), a newly developed selective 5-HT2A agonist, and tested it with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects on locomotion. 25CN-NBOH evoked HTRs with an inverted u-shape-like dose-response curve and highest efficacy at 1.5 mg/kg, i.p. HTR occurrence peaked within 5 min after agonist injection, and exponentially decreased to half-maximal frequency at ~11 min. Thorough habituation to the experimental procedures (including handling, saline injection, and exposure to the observational boxes 1 day before the experiment) facilitated the animals' response to 25CN-NBOH. 25CN-NBOH (1.5 mg/kg, i.p.) induced HTRs were blocked by the 5-HT2A antagonist ketanserin (0.75 mg/kg, 30 min pre), but not by the 5-HT2C antagonist SB-242084 (0.5 mg/kg, i.p., 30 min pre). SB-242084 instead slightly increased the number of HTRs occurring at a 3.0-mg/kg dose of the agonist. Apart from HTR induction, 25CN-NBOH also modestly increased locomotor activity of the mice. Repeated once-per-day injections (1.5 mg/kg, i.p.) led to reduced occurrence of 25CN-NBOH induced HTRs. This intermediate tolerance was augmented when a second (higher) dose of the drug (3.0 mg/kg) was interspersed. Short-interval tolerance (i.e., tachyphylaxis) was observed when the drug was injected twice at intervals of 1.0 and 1.5 h at either dose tested (1.5 mg/kg and 0.75 mg/kg, respectively). Inducing ketanserin-sensitive HTRs, which are dependent on environmental valences and which show signs of tachyphylaxis and tolerance, 25CN-NBOH shares striking features common to serotonergic hallucinogens. Given its distinct in vitro selectivity for 5-HT2A over non5-HT2 receptors and its behavioral dynamics, 25CN-NBOH appears to be a powerful tool for dissection of receptor-specific cortical circuit dynamics, including 5-HT2A related psychoactivity.
first_indexed 2024-12-11T08:16:04Z
format Article
id doaj.art-636ec90072f741e38ebece1e364bb296
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T08:16:04Z
publishDate 2018-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-636ec90072f741e38ebece1e364bb2962022-12-22T01:14:46ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-02-01910.3389/fphar.2018.00017322715Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in MiceTobias Buchborn0Taylor Lyons1Thomas Knöpfel2Thomas Knöpfel3Laboratory for Neuronal Circuit Dynamics, Department of Medicine, Imperial College London, London, United KingdomLaboratory for Neuronal Circuit Dynamics, Department of Medicine, Imperial College London, London, United KingdomLaboratory for Neuronal Circuit Dynamics, Department of Medicine, Imperial College London, London, United KingdomCentre for Neurotechnology, Institute of Biomedical Engineering, Imperial College London, London, United KingdomThe serotonin (5-HT) 2A receptor is the primary molecular target of serotonergic hallucinogens, which trigger large-scale perturbations of the cortex. Our understanding of how 5-HT2A activation may cause the effects of hallucinogens has been hampered by the receptor unselectivity of most of the drugs of this class. Here we used 25CN-NBOH (N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine), a newly developed selective 5-HT2A agonist, and tested it with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects on locomotion. 25CN-NBOH evoked HTRs with an inverted u-shape-like dose-response curve and highest efficacy at 1.5 mg/kg, i.p. HTR occurrence peaked within 5 min after agonist injection, and exponentially decreased to half-maximal frequency at ~11 min. Thorough habituation to the experimental procedures (including handling, saline injection, and exposure to the observational boxes 1 day before the experiment) facilitated the animals' response to 25CN-NBOH. 25CN-NBOH (1.5 mg/kg, i.p.) induced HTRs were blocked by the 5-HT2A antagonist ketanserin (0.75 mg/kg, 30 min pre), but not by the 5-HT2C antagonist SB-242084 (0.5 mg/kg, i.p., 30 min pre). SB-242084 instead slightly increased the number of HTRs occurring at a 3.0-mg/kg dose of the agonist. Apart from HTR induction, 25CN-NBOH also modestly increased locomotor activity of the mice. Repeated once-per-day injections (1.5 mg/kg, i.p.) led to reduced occurrence of 25CN-NBOH induced HTRs. This intermediate tolerance was augmented when a second (higher) dose of the drug (3.0 mg/kg) was interspersed. Short-interval tolerance (i.e., tachyphylaxis) was observed when the drug was injected twice at intervals of 1.0 and 1.5 h at either dose tested (1.5 mg/kg and 0.75 mg/kg, respectively). Inducing ketanserin-sensitive HTRs, which are dependent on environmental valences and which show signs of tachyphylaxis and tolerance, 25CN-NBOH shares striking features common to serotonergic hallucinogens. Given its distinct in vitro selectivity for 5-HT2A over non5-HT2 receptors and its behavioral dynamics, 25CN-NBOH appears to be a powerful tool for dissection of receptor-specific cortical circuit dynamics, including 5-HT2A related psychoactivity.http://journal.frontiersin.org/article/10.3389/fphar.2018.00017/fullserotonergic hallucinogen25CN-NBOH5-HT2A receptor5-HT2C receptorhead twitch responsetachyphylaxis
spellingShingle Tobias Buchborn
Taylor Lyons
Thomas Knöpfel
Thomas Knöpfel
Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
Frontiers in Pharmacology
serotonergic hallucinogen
25CN-NBOH
5-HT2A receptor
5-HT2C receptor
head twitch response
tachyphylaxis
title Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
title_full Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
title_fullStr Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
title_full_unstemmed Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
title_short Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
title_sort tolerance and tachyphylaxis to head twitches induced by the 5 ht2a agonist 25cn nboh in mice
topic serotonergic hallucinogen
25CN-NBOH
5-HT2A receptor
5-HT2C receptor
head twitch response
tachyphylaxis
url http://journal.frontiersin.org/article/10.3389/fphar.2018.00017/full
work_keys_str_mv AT tobiasbuchborn toleranceandtachyphylaxistoheadtwitchesinducedbythe5ht2aagonist25cnnbohinmice
AT taylorlyons toleranceandtachyphylaxistoheadtwitchesinducedbythe5ht2aagonist25cnnbohinmice
AT thomasknopfel toleranceandtachyphylaxistoheadtwitchesinducedbythe5ht2aagonist25cnnbohinmice
AT thomasknopfel toleranceandtachyphylaxistoheadtwitchesinducedbythe5ht2aagonist25cnnbohinmice